表纸
市场调查报告书

腐蚀性食道炎 (糜烂性食道炎) :全球临床实验趋势

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2019

出版商 GlobalData 商品编码 332926
出版日期 内容资讯 英文 144 Pages
订单完成后即时交付
价格
Back to Top
腐蚀性食道炎 (糜烂性食道炎) :全球临床实验趋势 Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2019
出版日期: 2019年04月30日内容资讯: 英文 144 Pages
简介

本报告提供腐蚀性食道炎 (糜烂性食道炎) 相关临床研究的最新趋势分析,提供您各地区的临床实验数量,临床实验的各阶段进展,受验者采用状况,有潜力的赞助商,各企业和研究机关的研究进展,有潜力的药剂比较等资讯。

简介

  • 腐蚀性食道炎 (糜烂性食道炎)
  • 本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要5国的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲主要国家的临床实验数量
    • 中南美主要国家的临床实验数量

G7各国临床实验数量:肠胃疾病治疗药临床实验上腐蚀性食道炎 (糜烂性食道炎) 的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

E7各国临床实验数量:肠胃疾病治疗药临床实验上腐蚀性食道炎 (糜烂性食道炎) 的比例

E7各国的各阶段临床实验数量

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

一定期间所采用的实验对像

赞助商类别的临床实验数量

有潜力的赞助商

腐蚀性食道炎 (糜烂性食道炎) 治疗药临床实验主要的参与企业

有潜力的药剂

临床实验简介

  • 主要企业临床实验概要
    • 武田药品工业
    • AstraZeneca PLC
    • Pfizer Inc.
    • Hammersmith Medicines Research Ltd.
    • CJ HealthCare Corporation
    • Kremers Urban Pharmaceuticals Inc.
    • Khorakiwala Holdings and Investments Private Limited
    • Ilyang Pharmaceutical Co., Ltd
    • Eisai
    • Effexus Pharmaceuticals LLC
  • 有代表性的研究机关·医院临床实验概要
    • Mayo Clinic
    • Chang Gung Memorial Foundation
    • Emory University
    • Landspitali University Hospital
    • Otto-von-Guericke Universitat
    • The Comprehensive and Integrative Medicine Institute of South Korea

5个有代表性的临床实验简介

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC5618CTIDB

GlobalData's clinical trial report, "Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2019" provides an overview of Corrosive Esophagitis (Erosive Esophagitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Corrosive Esophagitis (Erosive Esophagitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Clinical Trials by G7 Countries: Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Region, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*
  • Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, G7 Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, E7 Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019*
  • Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, G7 Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, E7 Countries (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology
Back to Top